D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
FHTX holding history
Foghorn Therapeutics Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
FHTX overviewAll 13F holders of FHTXFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −14,875−100.0% | Sold out | Holders |
| Q1 2025 | 14,875 | $54.3K | <0.1% | −85,492−85.2% | Reduced | Holders |
| Q4 2024 | 100,367 | $473.7K | <0.1% | +30,671+44.0% | Added | Holders |
| Q3 2024 | 69,696 | $648.9K | <0.1% | +43,958+170.8% | Added | Holders |
| Q2 2024 | 25,738 | $148.0K | <0.1% | +25,738 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −19,855−100.0% | Sold out | Holders |
| Q1 2022 | 19,855 | $302.0K | <0.1% | +5,687+40.1% | Added | Holders |
| Q4 2021 | 14,168 | $324.0K | <0.1% | +14,168 | New | Holders |